Support & Solvents
Injection Kit
50 syringes + 100 padsEverything required to safely reconstitute and inject reconstituted peptides — 50 sterile insulin syringes plus 100 alcohol prep pads.
$25
Lyophilized · 5 mg + 5 mg / vial
Growth & Anabolic
5 mg + 5 mg / vial
CJC-1295 + Ipamorelin Blend (5mg + 5mg)
GHRH + selective GHRP synergistic stack · Co-lyophilized · Single vial, one injection
Premium Grade
Bestseller
Co-lyophilized GHRH + selective GHRP stack — the reference combination for synergistic pulsatile GH release.
- CAS Number
- Blend
- Molecular Weight
- Mixed (3 368 + 712 Da)
- Purity
- ≥ 99.0% (HPLC, each component)
- Storage
- −20 °C, lyophilized
Amino Acid Sequence
CJC-1295 (Mod GRF 1-29) co-lyophilized with Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
Free over $59$7.99 to US (48h) · $14.99 worldwide (5 business days)
Discreet PackagingPlain insulated mailer, no compound name on the outside.
Certificate of Analysis
Per-lot analytical report — HPLC, ESI-MS, LAL endotoxin, heavy metals, sterility
Current lotCJC772
Released2026-04-17
HPLC purity99.77%
Endotoxin (LAL)Pass · < 0.5 EU/mg
About CJC-1295 No DAC + Ipamorelin Blend
Buy the CJC-1295 + Ipamorelin blend at IGF1 Shop. This pre-blended vial contains 5mg of CJC-1295 (No DAC, also called Modified GRF 1-29) co-lyophilized with 5mg of Ipamorelin in a single vial — the reference GHRH + GHRP combination for synergistic pulsatile growth hormone release. CJC-1295 No DAC primes the pituitary via the GHRH receptor; Ipamorelin selectively triggers the release via the ghrelin receptor (GHS-R1a). The two combined produce a GH pulse two to five times larger than either alone, without raising cortisol or prolactin. Each blend lot is HPLC ≥99% for each component, mass-spec verified, with a per-lot COA.
Also known as: CJC-1295 Ipamorelin · CJC + Ipamorelin blend · GHRH/GHRP stack · Mod GRF + Ipamorelin
CJC-1295 No DAC + Ipamorelin Blend — Mechanism & Specifications
This blend co-lyophilizes the foundational GHRH analog (Mod GRF 1-29) with the selective ghrelin-receptor agonist Ipamorelin in a single vial. The two compounds activate distinct receptors on somatotrophs and produce a synergistic GH pulse far greater than either compound alone, without elevating cortisol or prolactin.
Quality & release criteria
Every lot of CJC-1295 No DAC + Ipamorelin Blend is released only after passing reverse-phase HPLC (≥ 99% area purity at 220 nm against a reference standard), ESI mass spectrometry confirmation of molecular weight, and Limulus Amebocyte Lysate (LAL) endotoxin testing below 0.5 EU/mg. The lot-specific Certificate of Analysis is provided with the order and available on request before purchase.
$102
3 vials · $34/vial
FAQ
CJC-1295 No DAC + Ipamorelin Blend — Frequently asked questions
Why blend CJC-1295 (No DAC) with Ipamorelin?
CJC-1295 No DAC is a GHRH analog — it primes the pituitary to release GH. Ipamorelin is a selective GHRP — it triggers the actual release through the ghrelin receptor pathway. Combined, the two produce a GH pulse that is synergistic, two to five times larger than either compound alone, without raising cortisol or prolactin.
What is the standard blend protocol?
The most common protocol is 100 mcg of each peptide together, one to three times per day, subcutaneously. Many users dose once first thing in the morning (fasted) and once 30 minutes before bed. With a 5mg + 5mg blend vial reconstituted in 2mL bacteriostatic water, 0.04mL (4 units on a U-100) delivers 100mcg of each.
How long until effects are noticeable?
Sleep quality typically improves within the first week of the CJC-1295 + Ipamorelin blend. Recovery, skin quality, and body-composition changes generally appear after 4-8 weeks of consistent dosing. Most users run blocks of 8-12 weeks followed by a 4-week break to prevent receptor desensitization.
How should the vial be reconstituted and stored?
Add 2mL of bacteriostatic water down the side of the vial, swirl until clear, do not shake. Keep refrigerated at 2-8 °C and use within 30 days of reconstitution. Pre-reconstitution shelf life of the lyophilized blend is two years at -20 °C.
What purity testing does the blend carry?
Each peptide in the CJC-1295 + Ipamorelin blend is independently HPLC ≥99%, then co-lyophilized in a 1:1 mass ratio in the same vial. Identity is confirmed by ESI mass-spec, endotoxin by LAL <0.5 EU/mg, sterility per USP <71>. The COA is issued by an ISO 17025 laboratory and tied to your lot.
Can I run the blend with other peptides like BPC-157 or TB-500?
Yes — the CJC-1295 + Ipamorelin blend is commonly stacked with healing peptides like BPC-157 or TB-500, taken in separate syringes at different times of day. Avoid stacking with other GHRP/GHRH peptides simultaneously, as it provides no added benefit and accelerates receptor desensitization.
